AU2003299359A1 - (3r, 4r)-4-'3-(s)-hydroxy-3-(6-mehtoxyquinolin-4-yl) propyli (-1-'2-(2-thienylthio) ethyl )ipiperidine-3-carboxylic acid crystalline form - Google Patents

(3r, 4r)-4-'3-(s)-hydroxy-3-(6-mehtoxyquinolin-4-yl) propyli (-1-'2-(2-thienylthio) ethyl )ipiperidine-3-carboxylic acid crystalline form

Info

Publication number: AU2003299359A1
Authority: AU; Australia
Prior art keywords: mehtoxyquinolin; ipiperidine; propyli; thienylthio; hydroxy
Prior art date: 2002-12-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003299359A

Inventor

Pascal Billot

Jacques Bourget

Bernd Janocha

Sylvaine Lafont

Carole Neves

Marc Antoine Perrin

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Aventis Pharma SA

Original Assignee

Aventis Pharma SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-20

Filing date

2003-12-19

Publication date

2004-07-29

2003-12-19 Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA

2004-07-29 Publication of AU2003299359A1 publication Critical patent/AU2003299359A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

AU2003299359A 2002-12-20 2003-12-19 (3r, 4r)-4-'3-(s)-hydroxy-3-(6-mehtoxyquinolin-4-yl) propyli (-1-'2-(2-thienylthio) ethyl )ipiperidine-3-carboxylic acid crystalline form Abandoned AU2003299359A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0216418A FR2849034A1 (en)	2002-12-20	2002-12-20	New stable, monohydrated crystalline form C of 1-substituted 4-quinolylpropyl-piperidine-3-carboxylic acid derivative, useful as antibacterial agent or intermediate for crystalline form A
FR02/16418		2002-12-20
PCT/FR2003/003810 WO2004060886A1 (en)	2002-12-20	2003-12-19	(3r, 4r)-4-'3-(s)-hydroxy-3-(6-mehtoxyquinolin-4-yl) propyli [-1-'2-(2-thienylthio) ethyl ]ipiperidine-3-carboxylic acid crystalline form

Publications (1)

Publication Number	Publication Date
AU2003299359A1 true AU2003299359A1 (en)	2004-07-29

Family

ID=32406325

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003299359A Abandoned AU2003299359A1 (en)	2002-12-20	2003-12-19	(3r, 4r)-4-'3-(s)-hydroxy-3-(6-mehtoxyquinolin-4-yl) propyli (-1-'2-(2-thienylthio) ethyl )ipiperidine-3-carboxylic acid crystalline form

Country Status (3)

Country	Link
AU (1)	AU2003299359A1 (en)
FR (1)	FR2849034A1 (en)
WO (1)	WO2004060886A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200406413A (en)	2002-06-26	2004-05-01	Glaxo Group Ltd	Compounds
TW200409637A (en)	2002-06-26	2004-06-16	Glaxo Group Ltd	Compounds
EP1941469A1 (en)	2005-10-14	2008-07-09	Gemplus SA.	Smart card customizing

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6403610B1 (en) *	1999-09-17	2002-06-11	Aventis Pharma S.A.	Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them

2002
- 2002-12-20 FR FR0216418A patent/FR2849034A1/en active Pending
2003
- 2003-12-19 WO PCT/FR2003/003810 patent/WO2004060886A1/en not_active Ceased
- 2003-12-19 AU AU2003299359A patent/AU2003299359A1/en not_active Abandoned

Also Published As

Publication number	Publication date
FR2849034A1 (en)	2004-06-25
WO2004060886A1 (en)	2004-07-22

Similar Documents

Publication	Publication Date	Title
EP3045176B8 (en)	2018-12-12	Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydroisoindol-2-yl)-piperidine-2,6-dione
IL189359A0 (en)	2008-06-05	Novel process for the synthesis of 5 - (4 - fluorophenyl) - 1 - [2 - ((2r, 4r)- 4 - hydroxy - 6 - oxo -tetrahydro - pyran - 2 - yl) - ethyl] - 2 - isopropyl- 4 - phenyl - 1h - pyrrole - 3 - carboxylic acid phenylamide
AU2003257437A1 (en)	2004-02-09	Novel 2,5-disubstituted pyrimidine derivatives
AU2003278406A1 (en)	2004-05-13	Amorphous form of esomeprazole salts
PL375818A1 (en)	2005-12-12	Process for preparing optically pure active compounds
AU2003299648A1 (en)	2004-06-30	Substituted 4-phenyl-(1,3)-dioxanes
WO2004043920A8 (en)	2005-07-21	Polymorphs of bicifadine hydrochloride
WO2006059164A3 (en)	2006-08-17	Pyrrolopyridine-2-carboxylic acid amides
AU2003245027A1 (en)	2004-11-01	Novel crystalline forms of ziprasidone hydrochloride
AU2003210812A1 (en)	2003-09-02	Stable pharmaceutical composition useful for treating gastrointestinal disorders
AU2003242072A1 (en)	2003-12-31	PROCESS FOR PRODUCING OPTICALLY ACTIVE Alpha-METHYLCYSTEINE DERIVATIVE
AU2003299359A1 (en)	2004-07-29	(3r, 4r)-4-'3-(s)-hydroxy-3-(6-mehtoxyquinolin-4-yl) propyli (-1-'2-(2-thienylthio) ethyl )ipiperidine-3-carboxylic acid crystalline form
AU2003213454A1 (en)	2003-09-22	Process for producing optically active sulfoxide derivative
AU2003252467A1 (en)	2004-01-23	Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives
AU2003235814A1 (en)	2003-07-24	Novel process for the preparation of trans-3- ethyl-2,5- dihydro-4- methyl-n-(2-( 4-(((((4-methyl cyclohexyl) amino)carbonyl) amino)sulfonyl) phenyl)ethyl) -2-oxo-1h-pyrrole -1-carboxamide
AU2003274518A1 (en)	2004-05-25	A process for the preparation of benzyl 2-oxo-4- (heteroaryl) dithio-alpha-isoprenyl-1- azetidineazetate derivatives
AU2003296069A1 (en)	2004-07-22	Composition for improving swallowing reflex failure
AU2003237069A1 (en)	2004-01-23	Process for producing optically active amide
AU2003303462A1 (en)	2004-07-22	Crystalline form of (3r,4r)-4-(3-(s)-hydroxy-3-(6-methoxyquinoline-4-yl)propyl)-1-(2-(2-thienylthio) ethyl)piperidine-3-carboxylic acid
AU2003217438A1 (en)	2004-10-11	Novel crystalline forms of levetiracetam
AU2003223098A1 (en)	2003-09-02	Novel process for the preparation of substantially pure 5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone
AU2003257407A1 (en)	2004-03-19	S-(+)-3-{1-(2-(2,3-dihydro-1h-indol-3-yl)ethyl)-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof
AU2003275592A1 (en)	2004-05-13	Process for producing optically active sulfoxide
EP1841739B8 (en)	2013-04-24	Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl] piperidine or salt thereof via novel intermediate
AU2003292449A1 (en)	2004-07-09	Process for the preparation of 3-(2-(3,4-dimethoxybenzoyl)-4,5- dimethoxyphenyl) -pentan-2-one

Legal Events

Date	Code	Title	Description
2005-09-15	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase